There are various types of injectable medications for weight loss, which can be injected into the stomach or other areas. These include commonly prescribed drugs such as Ozempic or Wegovy (semaglutide ...

The minimally-invasive technique is a game-changer as it reduces tissue damage, blood loss and postoperative pain, aiding faster recovery Listen to Story Endoscopic spine surgery is minimally invasive ...

Although the incidence of GISTs is rising in the oriental population ... the most common GI location of primary disease was stomach (59.0%), followed by small bowel (22.5%), duodenum (6.2% ...

The European Society for Medical Oncology (ESMO) guidelines recommend life-long systemic tyrosine kinase inhibitor (TKI) therapies for advanced gastrointestinal stromal tumours (GIST), in order to ...

Gastric bypass surgery is typically performed by a bariatric surgeon in a hospital under general anesthesia. The procedure takes under two hours, and the hospital stay is two to three days. Below is ...

Nine years after Saowanee Ngamruengphong, M.D., brought a minimally invasive stomach-saving procedure to Johns Hopkins, she is using it to treat more patients than ever, and is training others in the ...

H. Ma and S. Srivastava are joint first authors of this article. R. Sundar and P. Tan are joint corresponding and senior authors of this article.

Indicators for Gleevec nonadherence were cognitive functioning, global health status score, social support, gender and others in patients with GIST.

Some of the best stomach exercises for stronger abs include crunches, teasers, planks, and body-weight squats. A workout that includes these moves can maximize a limited schedule and leave your ...

6 Xuhui Hospital, Affiliated Zhongshan Hospital, Fudan University, Shanghai, China Subepithelial lesions (SLEs) are often detected incidentally during endoscopic examination ... (40.3%), but mostly in ...

CMG901 was active and had a manageable safety profile in a heavily pretreated population of patients with CLDN18.2-positive gastric/gastroesophageal junction cancer. Irrespective of PD-L1 expression, ...

Emerging treatments, particularly claudin 18.2, a potential new biomarker in the HER2-negative gastric and gastroesophageal junction cancer space, were highlights of the 2023 ASCO Gastrointestinal ...